Home › Therapeutic areas › Antipeptic ulcer agents
Japan market screening · Therapeutic class
消化性潰瘍用剤 · Japan Standard Commodity Classification
25 molecules in this class are marketed in Japan across 331 products. 56 of those products are not shipping normally today — 16.9% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.
Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.
| Molecule | Products | Companies | Constrained | Supply mix |
|---|---|---|---|---|
| Famotidineファモチジン | 76 | 20 | 7 | |
| Rabeprazole Sodiumラベプラゾールナトリウム | 57 | 19 | 14 | |
| Rebamipideレバミピド | 27 | 23 | 1 | |
| Esomeprazole Magnesium Hydrateエソメプラゾールマグネシウム水和物 | 20 | 9 | — | |
| Lansoprazoleランソプラゾール | 20 | 7 | 7 | |
| Sulpirideスルピリド | 17 | 4 | 2 | |
| Lafutidineラフチジン | 16 | 7 | — | |
| Omeprazoleオメプラゾール | 14 | 7 | 3 | |
| Cimetidineシメチジン | 12 | 6 | 9 | |
| Irsogladine Maleateイルソグラジンマレイン酸塩 | 11 | 4 | 2 | |
| Teprenoneテプレノン | 11 | 6 | 2 | |
| Aldioxaアルジオキサ | 7 | 3 | — | |
| Roxatidine Acetate Hydrochlorideロキサチジン酢酸エステル塩酸塩 | 6 | 2 | 2 | |
| Sodium Gualenate Hydrate / L-Glutamineアズレンスルホン酸ナトリウム水和物・Ｌ－グルタミン | 6 | 3 | 1 | |
| Nizatidineニザチジン | 4 | 2 | 2 | |
| Polaprezincポラプレジンク | 4 | 3 | — | |
| Sodium Alginateアルギン酸ナトリウム | 4 | 1 | — | |
| Sucralfate Hydrateスクラルファート水和物 | 4 | 3 | — | |
| Vonoprazan Fumarateボノプラザンフマル酸塩 | 4 | 1 | 2 | |
| Omeprazole Sodiumオメプラゾールナトリウム | 3 | 3 | 1 | |
| Egualen Sodium Hydrateエグアレンナトリウム水和物 | 2 | 1 | — | |
| Misoprostolミソプロストール | 2 | 1 | — | |
| Pirenzepine Hydrochloride Hydrateピレンゼピン塩酸塩水和物 | 2 | 2 | — | |
| Benexate Hydrochloride Betadexベネキサート塩酸塩 ベータデクス | 1 | 1 | — | |
| Cetraxate Hydrochlorideセトラキサート塩酸塩 | 1 | 1 | 1 |
Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.
Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.
Send an enquiryOur Database Division replies in English within three business days (Japan time).